Showing papers by "Bryan Burmeister published in 2022"
TL;DR: In this paper , the optimal neoadjuvant treatment for resectable locally advanced carcinoma of the thoracic esophagus (TE) or gastroesophageal junction (GEJ) remains a matter of debate.
TL;DR: In this paper , the authors used individual patient data from a network meta-analysis of neoadjuvant chemotherapy or chemoradiotherapy in esophageal or gastro-esophagal junction carcinoma (MANATEC-02) to evaluate the time between recurrence and death in each trial.
TL;DR: A 71-year-old female with a T3 oesophageal squamous cell carcinoma, who presented with new onset dysphagia 2 weeks after completing a course of definitive radiotherapy and was found to have a broncho-oesophageaal fistula is reported.
Abstract: Malignant tracheo-oesophageal fistula (TEF) can result from tumour progression and invasion of adjacent organs, or a complication of treatment. In the posttreatment setting, incidence of TEF in cases with preceding airway invasion (T4b) are not infrequently reported; however, for those for whom disease was confined to organ (T1–3) at staging, this is a rare complication. Management for these cases is palliative in nature, with the goal to prevent aspiration by closing the connection and facilitate safe resumption of oral intake where possible. Herein we report a case of a 71-year-old female with a T3 oesophageal squamous cell carcinoma, who presented with new onset dysphagia 2 weeks after completing a course of definitive radiotherapy and was found to have a broncho-oesophageal fistula. This patient was managed with dual stenting of both the airway and oesophagus, an emerging management option for this condition, and was thereafter able to safely resume oral intake.